| 14797-5 |
Iron |
Imp |
Ser/Plas |
Pt |
Nom |
|
|
ACTIVE |
Iron [Interpretation] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
14797-5 |
|
|
|
|
Observation |
|
|
|
0 |
Iron SerPl-Imp |
|
|
|
|
|
Chemistry; Fe; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.26 |
1.0k |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 14798-3 |
Iron |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Iron [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
14798-3 |
|
|
|
|
Both |
|
|
|
0 |
Iron SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Fe; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 14799-1 |
Iron |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Iron [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/d |
|
|
|
|
|
|
CHEM |
|
14799-1 |
|
|
|
|
Both |
|
|
|
0 |
Iron 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; Fe; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.4 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
| 148-7 |
Cephalexin |
Susc |
Isolate |
Pt |
Qn |
MLC |
|
ACTIVE |
Cephalexin [Susceptibility] by Minimum lethal concentration (MLC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
148-7 |
|
MLC |
|
|
Observation |
|
|
|
0 |
Cephalexin Islt MLC |
|
|
|
Y |
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefadine; GRACEF; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Keflex; Losporal; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Palitrex; Point in time; QNT; Quan; Quant; Quantitative; Random; Salitex; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 1480-3 |
Galactose^1H post 40 g galactose PO |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Galactose [Mass/volume] in Blood --1 hour post 40 g galactose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1480-3 |
|
|
|
|
Observation |
|
|
|
0 |
Galactose 1h p 40 g Gal PO Bld-mCnc |
|
|
|
Y |
|
1 hour; 1.0Hr; 1h p 40 g Gal PO; 60 min; 60 minutes; 60M; 60min; After; Blood; Cerebrose; CHEMISTRY.CHALLENGE TESTING; Galactose tolerance test; Level; Mass concentration; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.4 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 14800-7 |
Iron binding capacity |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Iron binding capacity [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
14800-7 |
|
|
|
|
Both |
|
|
|
0 |
TIBC SerPl-sCnc |
|
|
|
Y |
|
Bind; Chemistry; dTIBC; Fe; IBC; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TIBC; Total iron binding |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 14801-5 |
Iron saturation |
SFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Iron saturation [Molar fraction] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
(Fe/TIBC)/100 |
|
|
|
CHEM |
|
14801-5 |
|
|
|
|
Both |
|
|
|
0 |
Iron Satn SFr SerPl |
|
|
|
Y |
|
Chemistry; Fe; FE/TIBC; Iron Satn; Iron/Iron binding capacity.total; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SAT; Satn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction; Transferrin saturation |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 14802-3 |
Isopropanol |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Isopropanol [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14802-3 |
|
|
|
|
Both |
|
|
|
0 |
Isopropanol SerPl-sCnc |
|
|
|
Y |
|
2-propanol; c615; DRUG/TOXICOLOGY; Drugs; Isopropyl alcohol; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 14803-1 |
Lactate dehydrogenase |
CCnc |
Body fld |
Pt |
Qn |
Reaction: lactate to pyruvate |
|
ACTIVE |
Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
14803-1 |
|
Reaction: lactate to pyruvate |
|
|
Both |
|
|
|
0 |
LDH Fld L to P-cCnc |
|
|
|
Y |
|
2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; Fl; Fld; FLU; Fluid; L to P; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; Tumor marker; UniversalLabOrders |
2.73 |
1.0k |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
| 14804-9 |
Lactate dehydrogenase |
CCnc |
Ser/Plas |
Pt |
Qn |
Reaction: lactate to pyruvate |
|
ACTIVE |
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
14804-9 |
|
Reaction: lactate to pyruvate |
|
|
Both |
|
|
|
0 |
LDH SerPl L to P-cCnc |
|
|
|
Y |
|
2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; L to P; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders |
2.73 |
1.0k |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
| 14805-6 |
Lactate dehydrogenase |
CCnc |
Ser/Plas |
Pt |
Qn |
Reaction: pyruvate to lactate |
|
ACTIVE |
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
14805-6 |
|
Reaction: pyruvate to lactate |
|
|
Both |
|
|
|
0 |
LDH SerPl P to L-cCnc |
|
|
|
Y |
|
2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; P to L; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders |
2.73 |
1.0k |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
| 14806-4 |
Lactose.PO |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Lactose.PO [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
g |
|
|
|
|
|
|
DRUGDOSE |
|
14806-4 |
|
|
|
|
Observation |
|
|
|
0 |
Lactose PO Dose |
|
|
|
Y |
|
Dose med or substance; DRUG DOSES; Lactose PO; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0k |
|
|
|
|
|
|
|
g |
|
|
|
0 |
| 14807-2 |
Lead |
SCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Lead [Moles/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14807-2 |
|
|
|
|
Both |
|
|
|
0 |
Lead Bld-sCnc |
|
|
|
Y |
|
Blood; DRUG/TOXICOLOGY; Drugs; Level; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 14808-0 |
Lead |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Lead [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14808-0 |
|
|
|
|
Both |
|
|
|
0 |
Lead Ur-sCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 14809-8 |
Lead |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Lead [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/d |
|
|
|
|
|
|
DRUG/TOX |
|
14809-8 |
|
|
|
|
Both |
|
|
|
0 |
Lead 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; DRUG/TOXICOLOGY; Drugs; Painter's colic; PB; Plumbism; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.4 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
| 1481-1 |
Galactose^2H post 40 g galactose PO |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Galactose [Mass/volume] in Blood --2 hours post 40 g galactose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1481-1 |
|
|
|
|
Observation |
|
|
|
0 |
Galactose 2h p 400 g Gal PO Bld-mCnc |
|
|
|
Y |
|
120 min; 120 minutes; 120min; 2 hours; 2h p 400 g Gal PO; After; Blood; Cerebrose; CHEMISTRY.CHALLENGE TESTING; Galactose tolerance test; Level; Mass concentration; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.4 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 14810-6 |
Leukocytes |
NCnc |
Bronchial |
Pt |
Qn |
Manual count |
|
ACTIVE |
Leukocytes [#/volume] in Bronchial specimen by Manual count |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
14810-6 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
WBC # Bronch Manual |
|
|
|
Y |
|
#; ABS; absolute; absolutes; Bro; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.19 |
1.0k |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 14811-4 |
Leukocytes |
NCnc |
Pericard fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Leukocytes [#/volume] in Pericardial fluid by Manual count |
|
MIN |
DefinitionDescription |
|
|
10*6/L |
|
|
|
|
|
|
HEM/BC |
|
14811-4 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
WBC # Pcar Manual |
|
|
|
Y |
|
#; ABS; absolute; absolutes; Cardio; Cardiology; Cnt; Count; Count/volume; CT; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number concentration; Number Concentration (count/vol); Pcar; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.73 |
1.0k |
|
|
|
|
|
|
|
/uL |
|
|
|
0 |
| 14812-2 |
Lidocaine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lidocaine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14812-2 |
|
|
|
|
Both |
|
|
|
0 |
Lidocain SerPl-sCnc |
|
|
|
Y |
|
c232; c251; CLID; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Xylocaine |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 14813-0 |
Lipoprotein.alpha |
SCnc |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Lipoprotein.alpha [Moles/volume] in Serum or Plasma by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14813-0 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
HDL SerPl Elph-sCnc |
|
|
|
Y |
|
Alfa; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; HDL; HDL particle concentration; HDL particle number; High density lipoproteins; Level; Lip; Lipoprot; Lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.4 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 14814-8 |
Lipoprotein.beta |
SCnc |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Lipoprotein.beta [Moles/volume] in Serum or Plasma by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
14814-8 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
LDL SerPl Elph-sCnc |
|
|
|
Y |
|
B; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; LDL; LDL particle concentration; LDL particle number; Level; Lip; Lipoprot; Lipoproteins; Low density lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.4 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 14815-5 |
Lipoprotein.beta |
SCnc |
Ser/Plas |
Pt |
Qn |
Calculated |
|
ACTIVE |
Lipoprotein.beta [Moles/volume] in Serum or Plasma by calculation |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
14815-5 |
|
Calculated |
|
|
Observation |
|
|
|
0 |
LDL SerPl Calc-sCnc |
|
|
|
Y |
|
B; Calc; Calculation; Chemistry; LDL; LDL particle concentration; LDL particle number; Level; Lip; Lipoprot; Lipoproteins; Low density lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 14816-3 |
Lipoprotein.pre-beta |
SCnc |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Lipoprotein.pre-beta [Moles/volume] in Serum or Plasma by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
14816-3 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
VLDL SerPl Elph-sCnc |
|
|
|
Y |
|
B; Before; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; LDL particle concentration; LDL particle number; Level; Lip; Lipoprot; Lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Very low density lipoproteins; VLDL; VLDL particle concentration; VLDL particle number |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 14817-1 |
LORazepam |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
LORazepam [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14817-1 |
|
|
|
|
Both |
|
|
|
0 |
LORazepam SerPl-sCnc |
|
|
|
Y |
|
Addiction; Ativan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 14818-9 |
Lymphocytes/Leukocytes |
NFr |
Pericard fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Lymphocytes/Leukocytes in Pericardial fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14818-9 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Lymphocytes NFr Pcar Manual |
|
|
|
Y |
|
Cardio; Cardiology; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Pcar; Percent; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
